For TrimRx patients on a compounded semaglutide or tirzepatide protocol, the GLP-1 is doing the major metabolic work with strong evidence support
The best sources of protein for weight loss are nutrient dense, relatively lean and easy to digest: Fish and seafood such as salmon, tuna, white fish and prawns Skinless chicken or turkey in baked, grilled or stir fried dishes Eggs and egg whites Tofu and tempeh Greek yoghurt and cottage cheese (if you tolerate dairy) Legumes such as lentils, black beans and chickpeas High protein dairy alternatives fortified with calcium and vitamin D Try to include some protein at every meal and snack to support muscle maintenance, fullness and stable blood sugar
Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
What to Avoid During GLP-1 Treatment To optimize results: Limit alcohol, because it can cause blood sugar to drop too low Review oral medications with our team, because GLP-1 slows stomach emptying Maintain a balanced, protein-forward diet Commit to daily movement, even 20 minutes These small steps significantly enhance your progress
Super common soothing ingredient
